Credit Suisse Ag Y M Abs Therapeutics, Inc. Transaction History

Credit Suisse Ag

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$3.0 - $15.17 $3,819 - $19,311	-1,273 Reduced 5.1%	23,704 $115,000
Q3 2022 Nov 10, 2022	BUY	$13.96 - $19.67 $56,579 - $79,722	4,053 Added 19.37%	24,977 $360,000
Q2 2022 Aug 12, 2022	BUY	$8.22 - $15.13 $13,636 - $25,100	1,659 Added 8.61%	20,924 $317,000
Q1 2022 May 16, 2022	BUY	$6.55 - $17.42 $7,853 - $20,886	1,199 Added 6.64%	19,265 $228,000
Q4 2021 Feb 14, 2022	BUY	$15.51 - $29.31 $17,433 - $32,944	1,124 Added 6.63%	18,066 $294,000
Q3 2021 Nov 12, 2021	BUY	$27.47 - $37.31 $37,771 - $51,301	1,375 Added 8.83%	16,942 $483,000
Q2 2021 Aug 16, 2021	BUY	$25.45 - $37.64 $21,657 - $32,031	851 Added 5.78%	15,567 $527,000
Q1 2021 May 14, 2021	SELL	$29.16 - $51.96 $385,582 - $687,067	-13,223 Reduced 47.33%	14,716 $445,000
Q4 2020 Feb 12, 2021	SELL	$37.86 - $54.26 $58,190 - $83,397	-1,537 Reduced 5.21%	27,939 $1.38 Million
Q3 2020 Nov 13, 2020	SELL	$35.13 - $43.62 $269,798 - $335,001	-7,680 Reduced 20.67%	29,476 $1.13 Million
Q2 2020 Aug 12, 2020	BUY	$23.66 - $49.53 $378,134 - $791,588	15,982 Added 75.48%	37,156 $1.61 Million
Q1 2020 May 13, 2020	SELL	$14.39 - $35.8 $144,921 - $360,541	-10,071 Reduced 32.23%	21,174 $553,000
Q4 2019 Feb 12, 2020	BUY	$23.81 - $33.78 $519,772 - $737,417	21,830 Added 231.86%	31,245 $976,000
Q3 2019 Nov 12, 2019	BUY	$21.57 - $31.37 $203,081 - $295,348	9,415 New	9,415 $246,000

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $356M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.